A prognostic value of syndecan-1 in gastric cancer

Anticancer Research

Volumn 20, Issue 6 D, 2000, Pages 4905-4907

  Wiksten, J P ^a   Lundin, J ^a   Nordling, S ^a   Kokkola, A ^a   Haglund, C ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Gastric cancer; Immunohistochemistry; Prognosis; Syndecan 1

Indexed keywords

PROTEOHEPARAN SULFATE; SYNDECAN; SYNDECAN 1; UNCLASSIFIED DRUG;

ADULT; AGE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CELL ADHESION; CELL MATURATION; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; FEMALE; GENDER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROGNOSIS; PROTEOGLYCANS; STOMACH NEOPLASMS; SURVIVAL RATE; SYNDECAN-1; SYNDECANS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034451383     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Biology of the syndecans: A family of transmembrane heparan sulfate proteoglycans
2. Binding of human syndecan to extracellular matrix proteins
3. Suppression of tumor cell growth by syndecan-1 ectodomain
4. Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. Syndecans and glypican have distinct functions
5. Cell surface proteoglycan expression correlates with epithelial-mesenchymal interaction during tooth morphogenesis
6. Epithelial-mesenchymal interactions regulate the stage-specific expression of a cell surface proteoglycan, syndecan, in the developing kidney
7. Immunohistochemical localization of syndecan in mouse skin tumors induced by UV irradiation. Loss of expression associated with malignant transformation
8. Localization of syndecan-1 in human gastric mucosa associated with ulceration
9. Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck
10. Syndecan-1 expression has prognostic significance in head and neck carcinoma
11. Syndecan-1: A new prognostic marker in laryngeal cancer
12. Syndecan-1 expression in malignant mesothelioma: Correlation with cell differentiation, WT1 expression, and clinical outcome
13. Heparan sulfate proteoglycan expression in human lung-cancer cells
14. Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential
15. Regression models and lifetables